Title: Seroprevalence of Transfusion Transmitted Infection among Blood Donors in Government Blood Banks of Chhattishgarh: Retrospective 5 Years Study
Authors: Agrawal Prahlad Chandra, Naik Reena, Panda Kishori M., Chawda Hanish
DOI: https://dx.doi.org/10.18535/jmscr/v4i11.43
Background: Transfusion transmissible infection (TTI) is defined as any infection that is transmissible from person to- person through parenteral administration of blood or blood products. The occurrence of TTIs varies from country to country. So to measure their severity, WHO (World Health Organization) has recommended pre-transfusion blood test for Human immunodeficiency virus (HIV), Hepatitis B virus (HBV), Hepatitis C Virus (HCV) and Syphilis as mandatory. The present study is undertaken to assess the seroprevalence of these infectious markers in blood donors of Chhattishgarh state. Materials and Methods: HIV, HBV, HCV & VDRL tests were done either by rapid kit or by ELISA methods. The prevalence of positive test results were evaluated for 5 years from 2010-11 to 2014-15. Results: The total number of donors were 306,864, comprising of voluntary 238856 (77.83 %) and replacement donors 68008 (22.16%). The overall prevalence of transfusion-transmitted infection was 4681/306864 (1.5 %). The prevalence of HIV, HBV, HCV and VDRL among total blood units collected were 666 (0.21%), 2254 (0.73%), 615 (0.2%) & 1146 (0.36%) respectively. Majority 2254/4681 (48.1 %) of infection was HBV. Seropositivity for HIV, HBV, HCV showed annual decrease, but seropositivity for VDRL increased over time. Conclusions: This study showed increasing percentage of voluntary donors and decreasing seroprevalence of TTIs in Chhattisgarh except for VDRL, which showed increasing seroprevalence. Therefore, strict donor selection, increasing participation of voluntary donors, proper testing of donors blood using standard methods as well as NAT and maintaining good quality control can improve blood safety. Keywords: seroprevalence, transfusion transmitted infections, Chhattisgarh, voluntary donors, HBV). 1. Widmann F K(ed) : technical manual American association of blood bank.Aglington USA 1985;325-344. 2. Bihl F, Castelli D, Marincola F, Dodd RY, Brander C. 6. Transfusion-transmitted infections. J Transl Med 2007; 5 : 25. 3. Chiavetta JA, Maki E, Gula CA, Newman A. Estimated risk of 7. transfusion transmitted infection in the Canadian blood supply (1987-1996). Vox Sang 2000; 78 (Suppl 1): 360. 4. Sarin S K, Saxena R, Sundaram K R. Transfusion associated hepatitis, risks and estimates in Indian population in transfusion associated hepatitis. Diagnosis, treatment and prevention ,Sarin S K, Hess G eds;1st Edn. CBs publishers & distributors New Delhi 212-218,1998. 5. Hans R, Marwaha N. Nucleic acid testing-benefits and constraints. Asian J Transfus Sci 2014; 8 : 2-3. 6. Fernandes H, D’souza PF, D’souza PM. Prevalence of 3. transfusion transmitted infections in voluntary and replacement donors. Indian J Hematol Blood Transfus 2010; 26 : 89-91. 7. Lathamani K., Bhaktha G, Nayak S., Kotigadde S. Prevalence of HIV, HCV, HBV and Syphilis in Blood donors among the Dakshina Kannada District, India Int.J.Curr.Microbiol.App.Sci (2013) 2(10): 249-252 8. Glynn SA, Kleinman SH, Wright DJ, Bush MP. For the NHLBI retrovirus epidemiology donor study: International application of incidence rate/ window period model. Transfusion 2002; 42: 966-72. 9. Shah N, Shah J.M. , Jhaveri P, Patel K, Shah C.K., Shah N.R. Sero prevalence of HBV, HCV, HIV and syphilis among blood donors at a tertiary Care Teaching Hospital in Western India GUJARAT MEDICAL JOURNAL ,2013 ; 68: 35 39 10. Pahuja S, Sharma M, Baitha B, Jain M. Prevalence and trends 8. of markers of hepatitis C virus, hepatitis B virus and human immunodeficiency virus in Delhi blood donors. a hospital based study. Jpn J Infect Dis 2007; 60 : 389-91. 11. Teo KS, Saparudin MS, Zain Z, Morshidi MA, Metassan N, Jaberudin R, Teo BC, Yakup S, Lim A, Ashikin NW. Transfusion transmissible infections in Brunei Darussalam: a blood donor study. Brunei Int Med J. 2011;7(6):321–327. 12. Saghir SAM, Hassan FMA, Alsalahi OSA, Alhariry AEAA, Baqir HS. Frequencies of HBV, HCV, HIV, and syphilis markers among blood donors: a hospital-based study in Hodeidah, Yemen. Trop J Pharm Res. 2012;11(1):132–136. doi: 10.4314/tjpr.v11i1.17. 13. Abdallah TM, Ali AAA. Sero-prevalence of transfusion-transmissible infectious diseases among blood donors in Kassala, eastern Sudan. J Med Med Sci. 2012;3(4):260–262. 14. Sharma RR, Cheema R, Vajpayee M, Rao U, Kumar S, Marwaha N, et al. Prevalance of markers of transfusion transmissible diseases in voluntary and replacement blood donors. The national medical journal of india 2004; 171: 19 -21. 15. Paramjit K, Basu S. Transfusion transmitted infections: Existing and emerging pathogens. Journal of post graduate medicine 2005;51:146–51. 16. World health organization South-East Asia Regional Office. Prevention of hepatitis B in India-an overview. Available from: whqlibdoc.who.int/searo/2002/SEA_Hepat.-5.pdf, accessed on June 10, 2014. 17. Chandrasekaran S, Palaniappan N, Krishnan V, Mohan G, Chandrasekaran N. Relative prevalence of hepatitis B viral markers and hepatitis C virus antibodies (Anti HCV) in Madurai, South india. Indian journal of medical sciences 2000;547:270-73 18. Khan MA, Rehaman A, Ashraf M, Ali A, Detta A. Prevalance of HPV, HCV and HIV in blood donors at Liaquatpur. Professional med j 2006;13:23-26. 19. Khan Z, Raziq F, Aslam N. Prevalance of HIV in blood doors in NWFP. J Postgrad med inst 2002;16:187-89. 20. Saha SK, Banik RK, Saha MR, Habibullah MM, Mahtab MA. Prevalance of transfusion transmitted infectio in healthy blood donors in sir Salimullah medical college Dhaka, Bangladesh. Euroasian journals of hepato-gastroenterology, 2011;1:68-70.Abstract
References